VARIATION OF ESTROGEN AND PROGESTERONE-RECEPTOR STATUS IN BREAST-CANCER
- 1 January 1985
- journal article
- research article
- Vol. 17 (1), 10-14
Abstract
In a series of 50 breast cancer patients, 2 estrogen and progesterone receptor assays were performed. In 2 simultaneous assays (tissue samples taken at the same time) disordant results in estrogen receptor, progesterone receptor and double receptor status were detected in 12%, 12% and 21% of cases respectively. In sequential assays (tissue samples taken with an interval between the samples) this variation was more pronounced, 24%, 36% and 36% respectively. The variation in simultaneous assays was similar between 2 samples of the same primary tumor as between samples from a primary tumor and a metastasis. In sequential assays there was no difference in the time between assays in concordant and discordant samples. The variation in receptor status is said to be due to the heterogeneity within the primary tumor.This publication has 6 references indexed in Scilit:
- Progesterone Receptors as a Prognostic Factor in Stage II Breast CancerNew England Journal of Medicine, 1983
- Variation of receptor status in cancer of the breastBritish Journal of Cancer, 1983
- Distribution of Estrogen and Progesterone Receptors on Primary Tumor and Lymph Nodes in Individual Patients with Breast CancerOncology, 1982
- Female sex steroid receptor status in primary and metastatic breast carcinoma and its relationship to serum steroid and peptide hormone levelsInternational Journal of Cancer, 1980
- Comparison of Estrogen Receptor Levels in Primary and Regional Metastatic Carcinoma of the BreastAnnals of Surgery, 1979
- Estrogen receptor protein (ERP) in multiple tumor specimens from individual patients with breast cancerCancer, 1977